Rotavirus Current Affairs, GK & News

Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials

The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech.  At NIV Pune, the ..

Month: 

Category: 

Topics: 

GoI to expand WHO’s 3S programme in the country

The Government of India will expand the 3S programme-Smart Safety Surveillance of WHO in the country. The expansion is being done to make sure the vaccines distributed under universal immunization programme are safe and also to optimize post-marketing surveillance of priority drugs. 3S Programme in India The programme was introduced by WHO (World Health Organization) ..

Month: 

Category: 

Topics: 

Gujar Mal Modi Award for Science & Technology

The Modi Group hands out the Gujar Mal Modi (GM Modi) Award for Science and Technology to scientists and faculty for outstanding contributions to science.? What is the GM Modi Award for Science and Technology? The GM Modi award aims to acknowledge the excellence in scientific research and development being done by the faculty and ..

Category: 

Topics: 

Gagandeep Kang becomes India’s first female scientist to be elected Royal Society Fellow

The Royal Society of London has announced a list of 51 eminent scientists elected to its fellowship in the year 2019. Among these is Dr. Gagandeep Kang, who is now with the Translational Health Science and Technology Institute, Faridabad. With this feat, Dr. Kang has become the India’s first female scientist to be elected to ..

Topics: 

Rotavac becomes India’s first indigenously developed vaccine to be pre-qualified by WHO

India’s first indigenously developed vaccine “Rotavac” has been pre-qualified by the World Health Organisation (WHO). To be “pre-qualified” means that the vaccine can be sold internationally to several countries in Africa and South America. The vaccine was developed by the Hyderabad-based Bharat Biotech Limited (BBL) and was included in India’s national immunisation programme. The Rotavac ..

Topics: 

1 / 212